# Phase II Double-Blind, Placebo-Controlled Study of the Reinforcing Effects of Alprazolam in Patients With Anxiety

> **NCT00004373** · PHASE2 · COMPLETED · sponsor: **National Institute on Drug Abuse (NIDA)** · enrollment: 80 (—)

## Conditions studied

- Anxiety Disorder
- Panic Disorder

## Interventions

- **DRUG:** alprazolam

## Key facts

- **NCT ID:** NCT00004373
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-03
- **Primary completion:** —
- **Final completion:** 2001-03
- **Target enrollment:** 80 (—)
- **Last updated:** 2005-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004373, "Phase II Double-Blind, Placebo-Controlled Study of the Reinforcing Effects of Alprazolam in Patients With Anxiety". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00004373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*